The Question Is Whether To Buy Or Not To Buy Solid Biosciences Inc (NASDAQ: SLDB)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Solid Biosciences Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $13.32 and fluctuated between $15.05 as its day high and $12.89 as its day low. The current market capitalization of Solid Biosciences Inc is $502.96M. A total of 0.87 million shares were traded on the day, compared to an average of 350.16K shares.

In the most recent transaction, Ganot Ilan sold 139 shares of SLDB for 7.99 per share on Jan 29 ’24. After the transaction, the Director now owns 8,416 company shares. In a previous transaction on Jan 11 ’24, PERCEPTIVE ADVISORS LLC bought 3,410,713 shares at 5.53 per share. SLDB shares that Director owns now total 6,833,539.

Among the insiders who bought shares, RA CAPITAL MANAGEMENT, L.P. acquired of 904,160 shares on Jan 11 ’24 at a per-share price of $5.53. This resulted in the Director holding 4,192,216 shares of SLDB after the transaction. In another insider transaction, Tan Kevin sold 3,935 shares at $8.20 per share on Jan 09 ’24. Company shares held by the CFO & Treasurer now total 9,308.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SLDB has a high of $14.99 and a low of $1.81.

As of this writing, SLDB has an earnings estimate of -$0.65 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.52 per share and a lower estimate of -$1.09. The company reported an EPS of -$1.05 in the last quarter, which was 11.80% higher than expectations of -$1.19.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SLDB’s latest balance sheet shows that the firm has $207.78M in Cash & Short Term Investments as of fiscal 2021. There were $2.06M in debt and $23.60M in liabilities at the time. Its Book Value Per Share was $6.20, while its Total Shareholder’s Equity was $208.21M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLDB is Buy with a score of 4.56.

Most Popular

Related Posts